Home > Boards > US Listed > Medical - Healthcare > Mylan Inc. (MYL)

Mylan has restarted production of hydroxychloroquine sulfate tablets

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
AllGold818 Member Profile
 
Followed By 4
Posts 404
Boards Moderated 0
Alias Born 11/21/19
160x600 placeholder
Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL PR Newswire (US) - 9/15/2020 7:15:00 AM
Mylan and Pfizer Receive European Commission Approval for Proposed Combination of Mylan and Upjohn PR Newswire (US) - 9/15/2020 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2020 5:01:55 PM
Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference PR Newswire (US) - 9/9/2020 1:07:00 PM
Mylan to Present at the BofA Securities Virtual Global Healthcare Conference PR Newswire (US) - 9/9/2020 1:05:00 PM
Mylan to Acquire Aspen's Thrombosis Business in Europe PR Newswire (US) - 9/8/2020 2:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 8/31/2020 6:06:03 AM
Mylan and Biocon Biologics Announce Launch of Semglee™ (insulin glargine injection) in the U.S. to Expand Access for Patien... PR Newswire (US) - 8/31/2020 6:00:00 AM
Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP ... PR Newswire (US) - 8/28/2020 6:30:00 PM
Mylan Launches First U.S. Generic of Biogen MS Drug Tecfidera Dow Jones News - 8/19/2020 8:09:00 AM
Mylan Brings Critical Access to the Multiple Sclerosis Community by Launching a More Affordable Treatment Option Through a Fi... PR Newswire (US) - 8/19/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 6:02:47 PM
Mylan and Sesame Workshop Partner to Provide Socio-Emotional Support Resources to Families Impacted by COVID-19 PR Newswire (US) - 8/12/2020 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 5:28:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 8:45:22 AM
Mylan Reports Strong Second Quarter and First Half 2020 Results and Updates 2020 Guidance PR Newswire (US) - 8/6/2020 6:30:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 7/24/2020 5:22:43 PM
Mylan to Release Second Quarter 2020 Financial Results on Aug. 6, 2020 PR Newswire (US) - 7/22/2020 7:30:00 AM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/10/2020 5:22:53 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/9/2020 5:15:45 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/9/2020 5:11:08 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/9/2020 5:08:42 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/9/2020 5:06:28 PM
Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) Edgar (US Regulatory) - 7/9/2020 5:06:04 PM
Viatris Reveals Branding to Reflect New Company's Transformative Strategy PR Newswire (US) - 7/9/2020 8:31:00 AM
AllGold818   Tuesday, 05/05/20 02:57:42 PM
Re: None
Post # of 222 
Mylan has restarted production of hydroxychloroquine sulfate tablets at its manufacturing facility in the United States to meet the increased demand resulting from the potential effectiveness of the product in treating COVID-19. Earlier, the company announced a merger agreement with Upjohn, Pfizer's PFE off-patent branded and generic established medicines business, to create a new global pharmaceutical company. In November 2019, Mylan and Pfizer announced the name of the new company to be Viatris. Last month, the European Commission approved the combination of Mylan and Upjohn, conditioned upon the completion of the sale of certain products of the former in Europe. The merger is now anticipated to close in the second half of 2020 due to the unprecedented circumstances surrounding the COVID-19 pandemic. Further updates on the same will be keenly awaited.

MYL is expected to beat on earnings when it reports first-quarter 2020 results on May 11.


MYL

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences